Here are the most important news, trends and analysis that investors need to start their trading day:
1. Stock futures rise after S&P 500, Nasdaq broke 3-day losing streaks
Traders work on the floor of the New York Stock Exchange (NYSE), October 12, 2021.
Brendan McDermid | Reuters
2. Data on wholesale inflation, jobless claims out before the bell
3. Banks, health-related companies see shares rise on strong results
The pace of earnings season accelerated Thursday, with slew of banks reporting quarterly results before the bell and their shares moving higher in premarket trading.
4. FDA vaccine panel gets ready to consider Moderna, J&J boosters
A registered nurse applies a dose of the Moderna COVID-19 vaccine to Sarasota Hospital worker Larry Hammers, 62, at the Sarasota Memorial Hospital in Sarasota, Florida, September 24, 2021.
Shannon Stapleton | Reuters
The FDA’s vaccine advisory group meets Thursday to consider a booster for Moderna’s two-shot Covid regimen. FDA scientists on Tuesday declined to take a stance it. The agency’s panel then meets Friday to consider a booster for Johnson & Johnson’s one-dose vaccine and mix-and-match vaccine data. A highly anticipated NIH study, released Wednesday, suggests J&J recipients are better off getting a booster from Pfizer or Moderna. Also on Wednesday, the FDA said data provided by J&J suggests recipients may benefit from an additional dose. A booster of Pfizer’s two-shot vaccine was approved for certain groups of people last month.
5. Foreclosures surge as Covid mortgage bailouts expire
fstop123 | E+ | Getty Images
— Follow all the market action like a pro on CNBC Pro. Get the latest on the pandemic with CNBC’s coronavirus coverage.
Here are the most important news, trends and analysis that investors need to start their trading day:
1. Stock futures rise after S&P 500, Nasdaq broke 3-day losing streaks
Traders work on the floor of the New York Stock Exchange (NYSE), October 12, 2021.
Brendan McDermid | Reuters
2. Data on wholesale inflation, jobless claims out before the bell
3. Banks, health-related companies see shares rise on strong results
The pace of earnings season accelerated Thursday, with slew of banks reporting quarterly results before the bell and their shares moving higher in premarket trading.
4. FDA vaccine panel gets ready to consider Moderna, J&J boosters
A registered nurse applies a dose of the Moderna COVID-19 vaccine to Sarasota Hospital worker Larry Hammers, 62, at the Sarasota Memorial Hospital in Sarasota, Florida, September 24, 2021.
Shannon Stapleton | Reuters
The FDA’s vaccine advisory group meets Thursday to consider a booster for Moderna’s two-shot Covid regimen. FDA scientists on Tuesday declined to take a stance it. The agency’s panel then meets Friday to consider a booster for Johnson & Johnson’s one-dose vaccine and mix-and-match vaccine data. A highly anticipated NIH study, released Wednesday, suggests J&J recipients are better off getting a booster from Pfizer or Moderna. Also on Wednesday, the FDA said data provided by J&J suggests recipients may benefit from an additional dose. A booster of Pfizer’s two-shot vaccine was approved for certain groups of people last month.
5. Foreclosures surge as Covid mortgage bailouts expire
fstop123 | E+ | Getty Images
— Follow all the market action like a pro on CNBC Pro. Get the latest on the pandemic with CNBC’s coronavirus coverage.